Bénéfice-risque : le rapport introuvableBERGMANN, Jean-Francois.Concours médical (Paris). 2005, Vol 127, Num 28, pp 1584-1586, issn 0010-5309, 3 p.Article

Decision-Making When Data and Inferences Are Not Conclusive : Risk-Benefit and Acceptable Regret ApproachHOZO, Iztok; SCHELL, Michael J; DJULBEGOVIC, Benjamin et al.Seminars in hematology. 2008, Vol 45, Num 3, pp 150-159, issn 0037-1963, 10 p.Article

A Comprehensive Approach to Benefit―Risk Assessment in Drug DevelopmentSARAC, Sinan B; RASMUSSEN, Christian H; RASMUSSEN, Morten A et al.Basic & clinical pharmacology & toxicology (Print). 2012, Vol 111, Num 1, pp 65-72, issn 1742-7835, 8 p.Article

Un rapport bénéfice/risque indiscutablement élevé : BiothérapiesTRON, Francois.Concours médical (Paris). 2008, Vol 130, Num 9, pp 453-455, issn 0010-5309, 3 p.Article

Bénéfices et risques de la chirurgie bariatriqueDETRY, R.Louvain médical. 2007, Vol 126, Num 5, pp 160-162, issn 0024-6956, 3 p.Conference Paper

A Concise Display of Multiple End Points for Benefit-Risk AssessmentLEVITAN, B.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 1, pp 56-59, issn 0009-9236, 4 p.Article

Pour mieux soigner: des médicaments à écarterLa Revue Prescrire. 2013, Vol 33, Num 352, pp 138-142, issn 0247-7750, 5 p.Article

Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT)ROGAN, Walter J; AIMIN CHEN.Lancet (British edition). 2005, Vol 366, Num 9487, pp 763-773, issn 0140-6736, 11 p.Article

Steroid phobia and adherence-problems, solutions, impact on benefit/risk profileRAO, Vivek U; APTER, Andrea J.Immunology and allergy clinics of North America. 2005, Vol 25, Num 3, issn 0889-8561, vii, 581-595 [16 p.]Article

Principe de précaution et code de déontologie = Principle of precaution and code of ethicsGLORION, Bernard.Bulletin de l'Académie nationale de médecine. 2000, Vol 184, Num 5, pp 897-903, issn 0001-4079Conference Paper

Si j'étais plus mince... ou les effets de la fée Rapidominceur ! = If I were slimmer... or the effect of the Fastslim Fairy!LEMOINE, C.Obésité. 2008, Vol 3, Num 2, pp 89-91, issn 1951-5995, 3 p.Article

Current assessment of risk-benefit by regulators : Is it time to introduce decision analyses?HUGHES, D. A; BAYOUMI, A. M; PIRMOHAMED, M et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 2, pp 123-127, issn 0009-9236, 5 p.Article

Drug prophyaxis in general medical patients: does usage reflect the benefits and risks?HERZIG, Shoshana; ROTHBERG, Michael.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7860, pp 21-23, issn 1759-2151, 3 p.Article

Using a drug before the risks and benefits are known from a phase 3 clinical trial : Thoughts on compassionMILLER, Joan W.Archives of ophthalmology (1960). 2006, Vol 124, Num 7, pp 1029-1031, issn 0003-9950, 3 p.Article

Carotid artery stents for blunt cerebrovascular injury : Risks exceed benefits. DiscussionCOTHREN, C. Clay; MOORE, Ernest E; RAY, Charles E et al.Archives of surgery (Chicago, IL. 1960). 2005, Vol 140, Num 5, pp 480-486, issn 0004-0010, 7 p.Article

Prescrire moins pour prescrire mieux : BÂTIR L'AVENIR SUR DU SOLIDEMONTASTRUC, Jean-Louis; FARGE, Thierry; BLACHER, Jacques et al.La Revue Prescrire. 2014, Vol 34, Num 370, pp 602-610, issn 0247-7750, 9 p.Article

Children in the Public Benefit System at Risk of Maltreatment: Identification Via Predictive ModelingVAITHIANATHAN, Rhema; MALONEY, Tim; PUTNAM-HORNSTEIN, Emily et al.American journal of preventive medicine (Print). 2013, Vol 45, Num 3, pp 354-359, issn 0749-3797, 6 p.Article

Why collaborate with children in health research: an analysis of the risks and benefits of collaboration with childrenBIRD, Deborah; CULLEY, Lorraine; LAKHANPAUL, Monica et al.Archives of disease in childhood. Education and practice edition. 2013, Vol 98, Num 2, pp 42-48, issn 1743-0585, 7 p.Article

Recent advances toward defining the benefits and risks of erythrocyte transfusions in neonatesCHRISTENSEN, Robert D; ILSTRUP, Sarah.Archives of disease in childhood. Fetal and neonatal edition. 2013, Vol 98, Num 4, issn 1359-2998, F365-F372Article

Communicating benefit and riskBAGLIN, Trevor.British journal of haematology. 2009, Vol 146, Num 1, pp 31-33, issn 0007-1048, 3 p.Article

The Benefits of Risk Factor Prevention in Americans Aged 51 Years and OlderGOLDMAN, Dana P; YUHUI ZHENG; GIROSI, Federico et al.American journal of public health (1971). 2009, Vol 99, Num 11, pp 2096-2101, issn 0090-0036, 6 p.Article

Children's and Their Parents' Views on Facing Research Risks for the Benefit of Others. EditorialWENDLER, David; JENKINS, Tammara; REYNOLDS, William W et al.Archives of pediatrics & adolescent medicine. 2008, Vol 162, Num 1, issn 1072-4710, 9-14, 88-90 [9 p.]Article

Évaluation du service médical rendu des médicaments par la Commission de la Transparence : Parcours du médicament en France = Assessment of actual benefits of new drugs by the Transparency CommitteeLE JEUNNE, C.Journal français d'ophtalmologie. 2008, Vol 31, Num 1, pp 90-93, issn 0181-5512, 4 p.Article

Quatrième partie : Les autres éléments de la balance bénéfices-risques Traitements agressifs, effets indésirables : Mammographies et dépistage des cancers du seinLa Revue Prescrire. 2006, Vol 26, Num 272, pp 364-368, issn 0247-7750, 5 p.Article

A favourable benefit/risk ratio with efalizumab : A review of the clinical evidencePOULIN, Yves; PAPP, Kim A; CAREY, Wayne et al.Journal of cutaneous medicine and surgery. 2005, Vol 9, pp 10-17, issn 1203-4754, 8 p., SUP1Article